OBJECTIVE: To evaluate the use and effect of early administration of vaginal estrogen via a continuous low-dose estradiol vaginal ring placed immediatelyafter pelvic reconstructive surgery. METHODS: This was a randomized controlled trial of 65 postmenopausal women undergoing vaginal reconstructive surgery. The subjects were randomly assigned to receive an estradiol-releasing vaginal ring, placebo vaginal ring, or control without vaginal ring for 12 weeks immediately after vaginal reconstructive surgery. The primary outcome was tissue quality based on vaginal maturation 3 months postoperatively. Secondary outcome measures were subjective and objective signs of atrophy; vaginal pH; the presence of granulation tissue, microscopic inflammation, and major healing abnormalities; and the ability to tolerate an intravaginal ring. RESULTS: At 12 weeks, the estradiol ring group had a significantly improved maturation value (P<0.01) and objective atrophy assessment (P<0.01) compared with the placebo ring and control arms. Granulation tissue was increased in the placebo ring arm (P<0.01). Subjective atrophy scores did not differ among the groups (P=0.39). CONCLUSIONS: Early administration of vaginal estrogen after vaginal surgery via an estradiol-releasing ring is feasible and results in improved markers of tissue quality postoperatively compared to placebo and controls.
RCT Entities:
OBJECTIVE: To evaluate the use and effect of early administration of vaginal estrogen via a continuous low-dose estradiol vaginal ring placed immediately after pelvic reconstructive surgery. METHODS: This was a randomized controlled trial of 65 postmenopausal women undergoing vaginal reconstructive surgery. The subjects were randomly assigned to receive an estradiol-releasing vaginal ring, placebo vaginal ring, or control without vaginal ring for 12 weeks immediately after vaginal reconstructive surgery. The primary outcome was tissue quality based on vaginal maturation 3 months postoperatively. Secondary outcome measures were subjective and objective signs of atrophy; vaginal pH; the presence of granulation tissue, microscopic inflammation, and major healing abnormalities; and the ability to tolerate an intravaginal ring. RESULTS: At 12 weeks, the estradiol ring group had a significantly improved maturation value (P<0.01) and objective atrophy assessment (P<0.01) compared with the placebo ring and control arms. Granulation tissue was increased in the placebo ring arm (P<0.01). Subjective atrophy scores did not differ among the groups (P=0.39). CONCLUSIONS: Early administration of vaginal estrogen after vaginal surgery via an estradiol-releasing ring is feasible and results in improved markers of tissue quality postoperatively compared to placebo and controls.
Authors: David D Rahn; Renée M Ward; Tatiana V Sanses; Cassandra Carberry; Mamta M Mamik; Kate V Meriwether; Cedric K Olivera; Husam Abed; Ethan M Balk; Miles Murphy Journal: Int Urogynecol J Date: 2014-11-13 Impact factor: 2.894
Authors: Marianna Alperin; Steven Abramowitch; May Alarab; Maria Bortolini; Bryan Brown; Lindsey A Burnett; Kathleen A Connell; Margot Damaser; Raffaella de Vita; Caroline E Gargett; Marsha K Guess; Zeliha Guler; Renato Natal Jorge; Robert S Kelley; Mark Kibschull; Kristin Miller; Pamela A Moalli; Indira U Mysorekar; Megan R Routzong; Oksana Shynlova; Carolyn W Swenson; Marrisa A Therriault; Gina M Northington Journal: Int Urogynecol J Date: 2022-06-08 Impact factor: 1.932
Authors: Marianna Alperin; Steven Abramowitch; May Alarab; Maria Bortolini; Bryan Brown; Lindsey A Burnett; Kathleen A Connell; Margot S Damaser; Raffaella de Vita; Caroline E Gargett; Marsha K Guess; Zeliha Guler; Renato Natal Jorge; Robert S Kelley; Mark Kibschull; Kristin Miller; Pamela A Moalli; Indira U Mysorekar; Megan R Routzong; Oksana Shynlova; Carolyn W Swenson; Marrisa A Therriault; Gina M Northington Journal: Female Pelvic Med Reconstr Surg Date: 2022-05-24 Impact factor: 1.913
Authors: Eva V Vodegel; Arnoud W Kastelein; Charlotte H J R Jansen; Jacqueline Limpens; Sandra E Zwolsman; Jan-Paul W R Roovers; Carlijn R Hooijmans; Zeliha Guler Journal: Neurourol Urodyn Date: 2021-10-13 Impact factor: 2.367
Authors: David D Rahn; Holly E Richter; Vivian W Sung; Wilma I Larsen; Linda S Hynan Journal: Female Pelvic Med Reconstr Surg Date: 2021-01-01 Impact factor: 1.913